MetaADEDB 2.0 @ LMMD
itopride
(QQQIECGTIMUVDS-UHFFFAOYSA-N)
Structure
SMILES
COc1cc(ccc1OC)C(=O)NCc1ccc(cc1)OCCN(C)C
Type(s)
Investigational
ATC code(s)
A03FA07
Molecular Formula:
C20H26N2O4
Molecular Weight:
358.431
Log P:
2.9651
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
1
TPSA:
60.03
CAS Number(s):
122898-67-3
Synonym(s)
1.
itopride
2.
N-(p-(2-(dimethylamino)ethoxy)benzyl)veratramide hydrochloride
External Link(s)
MeSHC102254
PubChem Compound3792
ChEBI94809
CHEMBLCHEMBL2107457
DrugBankDB04924
DrugCentral1512
KEGGdr:D08094
ZINC537874
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abscess managementOFFSIDES
2AcidosisOFFSIDES
3Activation syndromeOFFSIDES
4Adverse eventOFFSIDES
5Alanine Aminotransferase IncreasedOFFSIDES
6Alcohol consumptionOFFSIDES
7Alcohol poisoningOFFSIDES
8Alcoholic IntoxicationOFFSIDES
9AmphetaminesOFFSIDES
10AnorexiaOFFSIDES
11Aphthous StomatitisOFFSIDES
12AppendicitisOFFSIDES
13AscitesOFFSIDES
14AutomatismOFFSIDES
15Benign Prostatic HyperplasiaOFFSIDES
16BlepharospasmOFFSIDES
17Blood alkaline phosphatase increasedOFFSIDES
18Blood amylase increasedOFFSIDES
19Blood electrolytes abnormalOFFSIDES
20Blood glucose decreasedOFFSIDES
21Blood lactate dehydrogenase increasedOFFSIDES
22Blood pH increasedOFFSIDES
23Blood potassium decreasedOFFSIDES
24Blood sodiumOFFSIDES
25Bone marrow depressionOFFSIDES
26Bone swellingOFFSIDES
27CataractOFFSIDES
28Catheter related infectionOFFSIDES
29Catheter site erythemaOFFSIDES
30CholecystitisOFFSIDES
31Completed SuicideOFFSIDES
32Compression fractureOFFSIDES
33Cubital Tunnel SyndromeOFFSIDES
34Dental abscessOFFSIDES
35Depressed Level of ConsciousnessOFFSIDES
36Depressed moodOFFSIDES
37Device related infectionOFFSIDES
38DiabetesOFFSIDES
39Diabetic Autonomic NeuropathyOFFSIDES
40Disseminated Intravascular CoagulationOFFSIDES
41DizzinessOFFSIDES
42Dry gangreneOFFSIDES
43DysgeusiaOFFSIDES
44Ejection Fraction DecreasedOFFSIDES
45Eye RednessOFFSIDES
46Feeling abnormalOFFSIDES
47Flank PainOFFSIDES
48Fluid overloadOFFSIDES
49Gamma-Glutamyltransferase IncreasedOFFSIDES
50Gastric ulcerOFFSIDES
51GlossitisOFFSIDES
52HiccoughOFFSIDES
53HypoxiaOFFSIDES
54Ileal ulcerOFFSIDES
55IncontinenceOFFSIDES
56IntussusceptionOFFSIDES
57LeukoencephalopathyOFFSIDES
58Lymphangiosis carcinomatosaOFFSIDES
59Malignant ascitesOFFSIDES
60Monocyte percentage decreasedOFFSIDES
61Muscle tightnessOFFSIDES
62NauseaOFFSIDES
63OliguriaOFFSIDES
64OsteomyelitisOFFSIDES
65Peptostreptococcus infectionOFFSIDES
66PeritonitisOFFSIDES
67Primary sequestrumOFFSIDES
68Procedural complicationOFFSIDES
69Protein total decreasedOFFSIDES
70Pulmonary congestionOFFSIDES
71Radiation PneumonitisOFFSIDES
72Residual urineOFFSIDES
73Risus sardonicusOFFSIDES
74Secretion dischargeOFFSIDES
75Ventricular FibrillationOFFSIDES
76Vertebral artery occlusionOFFSIDES
77Wound dehiscenceOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.